Stock data
Armata Pharmaceuticals, Inc. (ARMP)
Armata Pharmaceuticals, Inc. (ARMP) reported net income of -US$173.80M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$36.63M | -US$173.80M | — |
| 2024 | — | — | -US$42.44M | -US$18.92M | — |
| 2023 | — | — | -US$40.89M | -US$69.05M | — |
| 2022 | — | — | -US$36.95M | -US$36.92M | — |
| 2021 | — | — | -US$23.82M | -US$23.16M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | US$74.14M | — |
| 2026-03-31 | — | -US$115.35M | — |
| 2025-12-31 | — | -US$124.30M | — |
| 2025-09-30 | — | -US$26.68M | — |
| 2025-06-30 | — | -US$16.30M | — |
| 2025-03-31 | — | -US$6.53M | — |
| 2024-12-31 | — | US$2.60M | — |
| 2024-09-30 | — | -US$5.48M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.